72PCemiplimab, a human monoclonal anti-PD-1, plus...

Annals of Oncology 2018 / 12 Vol. 29; Iss. suppl_10

72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V, Gil-Martin, M, Johnson, M L, Aljumaily, R, Lopez Criado, P, Northfelt, D W, Crittenden, M, Jabbour, S, Rosen, L, Garrido, P, Hervás Morón, A, Rietschel, P, Mohan, K K, Li, J, Stankevich, E,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy487.003
Date:
December, 2018
File:
PDF, 77 KB
2018
Conversion to is in progress
Conversion to is failed